18 February 2018
News and Views
Links and Services
This week's New England Journal of Medicine measures disease activity and clinical remission in ulcerative colitis after ozanimod induction.
Ozanimod (RPC1063) is an oral agonist of the sphingosine-1-phosphate receptor subtypes
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors